ALQGC — Quantum Genomics SA Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Quantum Genomics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 27.2 | 13.6 | 10.4 | 3.55 | 0.301 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.85 | 3.57 | 12.9 | 0.119 | 0.027 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 33.5 | 21.4 | 23.4 | 3.69 | 0.353 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.027 | 0.03 | 0.023 | 0.008 | 0.001 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 35 | 22.6 | 23.7 | 3.75 | 0.355 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.64 | 10.2 | 19.4 | 1.35 | 0.68 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.1 | 11 | 20 | 3.31 | 2.81 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 27.9 | 11.6 | 3.65 | 0.437 | -2.46 |
| Total Liabilities & Shareholders' Equity | 35 | 22.6 | 23.7 | 3.75 | 0.355 |
| Total Common Shares Outstanding |